Intelligent Solutions in Pharmacy Benefits
On Friday, March 31, the FDA alerted consumers to the voluntary recall of 13 lots of Mylan's EpiPen and EpiPen Jr Auto-Injector products that are used for emergency treatment of severe allergic reactions. The recalled products were distributed from December 2015 through July 2016. These devices may contain a defective part that could result in its failure to activate. This recall impacts the 0.3mg and 0.15mg strengths.
For updates, lot numbers and additional information, go to: www.Mylan.com/EpiPenRecall.
Consumers should keep and use their current EpiPen products, if needed, until they get a replacement. If you have a recalled EpiPen product, contact Stericycle to provide a container to return the recalled medication. You will also receive a voucher to redeem for a free replacement product. Please contact Stericycle at 877-650-3494.
If you have any questions or concerns, contact Mylan Customer Relations at 800-796-9526 or at email@example.com .
PBIRx has notified all clients and brokers of this recall and will always be proactive to our consumers when we receive important pharmacy information that may impact their health.
PBIRx has been exclusively providing intelligent solutions to clients in the management of pharmacy benefit costs since 1993. With a staff that includes IT personnel, actuaries, financial analysts, clinical pharmacists, attorneys, HIPAA Compliance Officers and many more experts, PBIRx’s mission is to create optimal health care outcomes while minimizing overall health care costs. For more information, please visit www.pbirx.com or call (888) 797-2479.